We are live on ! Find out more
NRXP icon

NRX Pharmaceuticals
NRXP

18 hedge funds and large institutions have $18.9M invested in NRX Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

6,011% more capital invested

Capital invested by funds: $310K → $18.9M (+$18.6M)

600% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 2

200% more funds holding

Funds holding: 6 → 18 (+12)

0.31% more ownership

Funds ownership: 0.03% → 0.34% (+0.31%)

Holders
18
Holders Change
+12
Holders Change %
+200%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$16.8M
2
LA
Linden Advisors
New York
+$9.62M
3
OCAM
Owl Creek Asset Management
New York
+$7.92M
4
Northern Trust
Northern Trust
Illinois
+$3.45M
5
HAG
HighPoint Advisor Group
Illinois
+$1.15M

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$253K
2
WAP
Wealthcare Advisory Partners
Pennsylvania
-$13K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$7.41M +$16.8M +63,742 New
LA
2
Linden Advisors
New York
$4.23M +$9.62M +36,435 New
OCAM
3
Owl Creek Asset Management
New York
$3.4M +$7.92M +30,000 New
Northern Trust
4
Northern Trust
Illinois
$1.52M +$3.45M +13,063 New
HAG
5
HighPoint Advisor Group
Illinois
$505K +$1.15M +4,350 New
Morgan Stanley
6
Morgan Stanley
New York
$463K +$1.03M +3,920 +5,851%
ICM
7
Ionic Capital Management
New York
$415K +$943K +3,572 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$400K +$910K +3,448 New
WAM
9
Wolverine Asset Management
Illinois
$226K +$514K +1,949 New
YCM
10
Yakira Capital Management
Connecticut
$139K +$315K +1,192 New
UBS Group
11
UBS Group
Switzerland
$97K +$221K +839 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$93K +$211K +800 New
Osaic Holdings
13
Osaic Holdings
Arizona
$38K +$78.1K +296 +846%
Carson Wealth (CWM LLC)
14
Carson Wealth (CWM LLC)
Nebraska
$4K – – –
Deutsche Bank
15
Deutsche Bank
Germany
$2K +$5.28K +20 New
TRCT
16
Tower Research Capital (TRC)
New York
$1K +$792 +3 +30%
SFPG
17
Stonebridge Financial Planning Group
Florida
$1K +$2.11K +8 New
Citigroup
18
Citigroup
New York
$1K +$2.38K +9 New
Jane Street
19
Jane Street
New York
– -$253K -715 Closed
WAP
20
Wealthcare Advisory Partners
Pennsylvania
– -$13K -38 Closed

NRXP Hedge Fund Activity: Q2 2021 in Review

18 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals (NRXP) for Q2 2021, worth a combined $18.9M — up 6,011% from $310K a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new NRXP positions and 2 closed out — a net gain of 12 holders — while 3 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, opening a new position worth an estimated $16.8M. The largest seller was Jane Street, exiting entirely with an estimated $253K sold.

  • 18 institutional investors held NRX Pharmaceuticals (NRXP) as of Q2 2021, up from 6 in Q1 2021.
  • Funds reported $18.9M of NRX Pharmaceuticals stock for Q2 2021, up 6,011% quarter-over-quarter.
  • 14 funds opened new NRX Pharmaceuticals positions in Q2 2021 and 2 closed out, a net change of +12 holders.
  • The largest NRX Pharmaceuticals buyer in Q2 2021 was Vanguard Group, an estimated $16.8M added.
  • The largest NRX Pharmaceuticals seller in Q2 2021 was Jane Street, an estimated $253K sold.

Based on aggregated 13F filings for Q2 2021.